Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
What You Missed On Wall Street This Morning » 12:10
06/01/22
06/01
12:10
06/01/22
12:10
BITF

Bitfarms

$1.89 /

-0.135 (-6.67%)

, CRM

Salesforce

$176.91 /

+16.31 (+10.16%)

, HPQ

HP Inc.

$39.75 /

+0.99 (+2.55%)

, SPGI

S&P Global

$337.39 /

-12.56 (-3.59%)

, DAL

Delta Air Lines

$39.67 /

-2.02 (-4.85%)

, OPA

Magnum Opus Acquisition

$9.79 /

-0.045 (-0.46%)

, RBAC

RedBall Acquisition

$9.95 /

+0.57 (+6.08%)

, TPX

Tempur Sealy

$24.99 /

-1.385 (-5.25%)

, VRTX

Vertex Pharmaceuticals

$267.07 /

-1.42 (-0.53%)

, BPMC

Blueprint Medicines

$55.22 /

+0.34 (+0.62%)

, GDRX

GoodRx

$7.36 /

-0.6 (-7.54%)

, MDT

Medtronic

$96.53 /

-3.64 (-3.63%)

, AAPL

Apple

$148.33 /

-0.48 (-0.32%)

, ENOB

Enochian Biosciences

$3.66 /

-1.595 (-30.38%)

, AFRM

Affirm

$24.33 /

-4.13 (-14.51%)

, SQ

Block

$82.73 /

-4.76 (-5.44%)

, TSLA

Tesla

$737.88 /

-20.13 (-2.66%)

, TWTR

Twitter

$39.51 /

-0.23 (-0.58%)

, META

Meta Platforms

/

+

, FB

Ticker changed to META

$193.20 /

-0.355 (-0.18%)

, CPRI

Capri Holdings

$49.03 /

+0.27 (+0.55%)

, VSCO

Victoria's Secret

$43.57 /

+2.295 (+5.56%)

, AMBA

Ambarella

$82.77 /

-2.46 (-2.89%)

, APPS

Digital Turbine

$19.97 /

-5.5 (-21.59%)

, HUM

Humana

$446.94 /

-6.58 (-1.45%)

, CMAX

CareMax

$5.30 /

+0.62 (+13.25%)

, NIO

Nio

$17.96 /

+0.55 (+3.16%)

, BARK

Bark

$2.17 /

-0.29 (-11.79%)

, LX

LexinFintech

$1.88 /

-0.135 (-6.70%)

Get caught up quickly on…

ShowHide Related Items >><<
VSCO Victoria's Secret
$43.57 /

+2.295 (+5.56%)

VRTX Vertex Pharmaceuticals
$267.07 /

-1.42 (-0.53%)

TWTR Twitter
$39.51 /

-0.23 (-0.58%)

TSLA Tesla
$737.88 /

-20.13 (-2.66%)

TPX Tempur Sealy
$24.99 /

-1.385 (-5.25%)

SQ Block
$82.73 /

-4.76 (-5.44%)

SPGI S&P Global
$337.39 /

-12.56 (-3.59%)

RBAC RedBall Acquisition
$9.95 /

+0.57 (+6.08%)

OPA Magnum Opus Acquisition
$9.79 /

-0.045 (-0.46%)

NIO Nio
$17.96 /

+0.55 (+3.16%)

META Meta Platforms
/

+

MDT Medtronic
$96.53 /

-3.64 (-3.63%)

LX LexinFintech
$1.88 /

-0.135 (-6.70%)

HUM Humana
$446.94 /

-6.58 (-1.45%)

HPQ HP Inc.
$39.75 /

+0.99 (+2.55%)

GDRX GoodRx
$7.36 /

-0.6 (-7.54%)

FB Ticker changed to META
$193.20 /

-0.355 (-0.18%)

ENOB Enochian Biosciences
$3.66 /

-1.595 (-30.38%)

DAL Delta Air Lines
$39.67 /

-2.02 (-4.85%)

CRM Salesforce
$176.91 /

+16.31 (+10.16%)

CPRI Capri Holdings
$49.03 /

+0.27 (+0.55%)

CMAX CareMax
$5.30 /

+0.62 (+13.25%)

BPMC Blueprint Medicines
$55.22 /

+0.34 (+0.62%)

BITF Bitfarms
$1.89 /

-0.135 (-6.67%)

BARK Bark
$2.17 /

-0.29 (-11.79%)

APPS Digital Turbine
$19.97 /

-5.5 (-21.59%)

AMBA Ambarella
$82.77 /

-2.46 (-2.89%)

AFRM Affirm
$24.33 /

-4.13 (-14.51%)

AAPL Apple
$148.33 /

-0.48 (-0.32%)

BITF Bitfarms
$1.89 /

-0.135 (-6.67%)

CRM Salesforce
$176.91 /

+16.31 (+10.16%)

06/01/22 RBC Capital
Salesforce margin outlook overshadowed lower revenue guide, says RBC Capital
06/01/22 BMO Capital
Salesforce price target lowered to $225 from $260 at BMO Capital
06/01/22 Stifel
Salesforce price target lowered to $250 from $300 at Stifel
06/01/22 Deutsche Bank
Salesforce price target lowered to $260 from $300 at Deutsche Bank
HPQ HP Inc.
$39.75 /

+0.99 (+2.55%)

06/01/22 Morgan Stanley
Morgan Stanley stays Underweight on HP Inc. after Q2 report
06/01/22 Citi
HP Inc. price target raised to $40 from $38 at Citi
06/01/22 Barclays
HP Inc. price target raised to $32 from $29 at Barclays
05/25/22 JPMorgan
HP Inc. price target lowered to $39 from $41 at JPMorgan
SPGI S&P Global
$337.39 /

-12.56 (-3.59%)

05/04/22 BMO Capital
S&P Global price target lowered to $433 from $462 at BMO Capital
05/04/22 Deutsche Bank
S&P Global price target lowered to $483 from $515 at Deutsche Bank
05/04/22 Credit Suisse
S&P Global price target lowered to $425 from $495 at Credit Suisse
05/04/22 UBS
S&P Global price target lowered to $441 from $486 at UBS
DAL Delta Air Lines
$39.67 /

-2.02 (-4.85%)

06/01/22 Goldman Sachs
Delta Air Lines price target raised to $45 from $44 at Goldman Sachs
04/26/22 Northland
SpaceX's Starlink deal with Hawaiian highlights risk for Gogo, says Northland
04/22/22 Morgan Stanley
United Airlines price target raised to $67 from $62 at Morgan Stanley
04/22/22 JPMorgan
Delta Air Lines price target raised to $70 from $69 at JPMorgan
OPA Magnum Opus Acquisition
$9.79 /

-0.045 (-0.46%)

03/01/22 Benchmark
Magnum Opus Acquisition initiated with a Buy at Benchmark
12/15/21 Cantor Fitzgerald
Magnum Opus Acquisition price target raised to $14.50 from $10.00 at Cantor Fitzgerald
10/21/21 Cantor Fitzgerald
Magnum Opus Acquisition initiated with an Overweight at Cantor Fitzgerald
RBAC RedBall Acquisition
$9.95 /

+0.57 (+6.08%)

TPX Tempur Sealy
$24.99 /

-1.385 (-5.25%)

06/01/22 Piper Sandler
Tempur Sealy downgraded to Neutral from Overweight at Piper Sandler
04/12/22 Loop Capital
Tempur Sealy price target lowered to $28 from $35 at Loop Capital
04/06/22 Raymond James
Tempur Sealy price target lowered to $38 from $45 at Raymond James
04/01/22 Piper Sandler
Tempur Sealy price target lowered to $34 from $40 at Piper Sandler
VRTX Vertex Pharmaceuticals
$267.07 /

-1.42 (-0.53%)

06/01/22 Maxim
Maxim upgrades Vertex Pharmaceuticals to Buy as company expands beyond CF
06/01/22 Maxim
Vertex Pharmaceuticals upgraded to Buy from Hold at Maxim
05/23/22 Piper Sandler
Piper Sandler remains bullish on Catalyst after sale of complement portfolio
05/23/22 SVB Securities
Vertex Pharmaceuticals initiated with a Market Perform at SVB Leerink
BPMC Blueprint Medicines
$55.22 /

+0.34 (+0.62%)

06/01/22 Jefferies
Blueprint Medicines raised to Buy at Jefferies after survey on Ayvakit in ISM
06/01/22 Jefferies
Blueprint Medicines upgraded to Buy from Hold at Jefferies
05/18/22 Piper Sandler
Blueprint Medicines price target lowered to $65 from $84 at Piper Sandler
05/04/22 Baird
Blueprint Medicines price target lowered to $96 from $123 at Baird
GDRX GoodRx
$7.36 /

-0.6 (-7.54%)

06/01/22 Baird
Baird downgrades GoodRx to Neutral amid disruption at Kroger
06/01/22 Baird
GoodRx downgraded to Neutral from Outperform at Baird
05/16/22 Baird
Baird 'hypothesizing' GoodRx PBM/pharmacy issue at Kroger may be improving
05/12/22 Wells Fargo
GoodRx price target lowered to $9 from $20 at Wells Fargo
MDT Medtronic
$96.53 /

-3.64 (-3.63%)

06/01/22 Atlantic Equities
Medtronic downgraded to Neutral from Overweight at Atlantic Equities
05/31/22 Raymond James
Medtronic price target lowered to $109 from $116 at Raymond James
05/31/22 Truist
Medtronic price target lowered to $111 from $121 at Truist
05/27/22 RBC Capital
Medtronic price target lowered to $122 from $135 at RBC Capital
AAPL Apple
$148.33 /

-0.48 (-0.32%)

06/01/22 Macquarie
Digital Turbine price target lowered to $40 from $70 at Macquarie
05/27/22 JPMorgan
iPhone China shipments in April below seasonal, says JPMorgan
05/25/22 Loop Capital
Loop Capital sees consensus for Apple's iPhone revenue in second half as low
05/24/22 BofA
Apple App Store growth has re-accelerated modestly, says BofA
ENOB Enochian Biosciences
$3.66 /

-1.595 (-30.38%)

AFRM Affirm
$24.33 /

-4.13 (-14.51%)

05/23/22 Mizuho
April delinquency trends promising for Affirm, says Mizuho
05/17/22 Mizuho
Affirm price target lowered to $50 from $79 at Mizuho
05/16/22 Barclays
Affirm price target lowered to $35 from $65 at Barclays
05/13/22 RBC Capital
Affirm price target lowered to $48 from $58 at RBC Capital
SQ Block
$82.73 /

-4.76 (-5.44%)

06/01/22 Piper Sandler
App downloads for Block's Cash App strong, says Piper Sandler
05/24/22 Morgan Stanley
Morgan Stanley upgrades Marqeta to Overweight on attractive entry point
05/23/22 Truist
Block price target lowered to $145 from $165 at Truist
05/23/22 Deutsche Bank
Block price target lowered to $155 from $180 at Deutsche Bank
TSLA Tesla
$737.88 /

-20.13 (-2.66%)

06/01/22 Goldman Sachs
Tesla price target lowered to $1,000 from $1,200 at Goldman Sachs
05/31/22 Mizuho
Tesla shutdown in Shanghai a near-term headwind, says Mizuho
05/27/22 Credit Suisse
Tesla pullback brings attractive entry point, says Credit Suisse
05/26/22 Jefferies
Jefferies cuts Tesla price target on governance risk, challenging market
TWTR Twitter
$39.51 /

-0.23 (-0.58%)

05/24/22 Jefferies
Twitter price target lowered to $40 from $48 at Jefferies
05/24/22 Wedbush
More fireworks expected heading into Twitter shareholder meeting, says Wedbush
05/24/22 KeyBanc
Snap price target lowered to $27 from $45 at KeyBanc
05/24/22 Bernstein
Bernstein says Tesla-Twitter saga far from over, discusses funding requirements
META Meta Platforms
/

+

05/10/22 BMO Capital
Yelp price target lowered to $37 from $42 at BMO Capital
04/06/22 DA Davidson
System1 price target raised to $26 from $23 at DA Davidson
03/25/22 UBS
Meta Platforms newsfeed changes and Reelz to drive higher monetization, says UBS
FB Ticker changed to META
$193.20 /

-0.355 (-0.18%)

06/01/22 Morgan Stanley
Meta Platforms price target lowered to $300 from $330 at Morgan Stanley
06/01/22 Morgan Stanley
Meta Platforms price target lowered to $300 from $330 at Morgan Stanley
05/24/22 Jefferies
Meta Platforms price target lowered to $310 from $330 at Jefferies
05/24/22 BofA
Snap price target lowered to $30 from $50 at BofA
CPRI Capri Holdings
$49.03 /

+0.27 (+0.55%)

04/19/22 OTR Global
Tapestry view downgraded to Mixed from Positive at OTR Global
04/19/22 Barclays
Capri Holdings price target raised to $74 from $72 at Barclays
04/05/22 Wells Fargo
Capri Holdings price target lowered to $85 from $95 at Wells Fargo
04/01/22 Barclays
Capri Holdings price target lowered to $72 from $85 at Barclays
VSCO Victoria's Secret
$43.57 /

+2.295 (+5.56%)

06/01/22 JPMorgan
Victoria's Secret price target lowered to $57 from $71 at JPMorgan
06/01/22 Wells Fargo
Victoria's Secret price target lowered to $60 from $70 at Wells Fargo
05/16/22 JPMorgan
Victoria's Secret price target lowered to $71 from $86 at JPMorgan
04/05/22 Wells Fargo
Victoria's Secret price target lowered to $70 from $75 at Wells Fargo
AMBA Ambarella
$82.77 /

-2.46 (-2.89%)

06/01/22 Craig-Hallum
Ambarella price target lowered to $100 from $170 at Craig-Hallum
06/01/22 Needham
Ambarella price target lowered to $120 from $175 at Needham
06/01/22 Morgan Stanley
Ambarella price target lowered to $114 from $122 at Morgan Stanley
06/01/22 Cowen
Ambarella price target lowered to $135 from $180 at Cowen
APPS Digital Turbine
$19.97 /

-5.5 (-21.59%)

06/01/22 Craig-Hallum
Digital Turbine price target lowered to $85 from $105 at Craig-Hallum
06/01/22 Oppenheimer
Digital Turbine price target lowered to $40 from $117 at Oppenheimer
02/16/22 Roth Capital
Roth says Google news creates more unwarranted noise around Digital Turbine
HUM Humana
$446.94 /

-6.58 (-1.45%)

05/26/22 Bernstein
Humana resumed with a Market Perform at Bernstein
04/28/22 Wells Fargo
Humana price target raised to $512 from $491 at Wells Fargo
04/13/22 UBS
Humana upgraded to Buy from Neutral at UBS
04/07/22 Truist
Humana price target raised to $490 from $460 at Truist
CMAX CareMax
$5.30 /

+0.62 (+13.25%)

05/11/22 Cowen
CareMax price target lowered to $8 from $11 at Cowen
01/07/22 UBS
CareMax initiated with a Buy at UBS
12/01/21 Piper Sandler
Piper Sandler remains buyer of CareMax after management meeting
11/15/21 Piper Sandler
Piper remains buyer of CareMax, likes share setup into Q4
NIO Nio
$17.96 /

+0.55 (+3.16%)

05/23/22 Mizuho
Nio could be back to pre-shutdown levels by June, says Mizuho
05/16/22 BofA
Nio upgraded to Buy at BofA on 'brighter' second half view
05/16/22 BofA
Nio upgraded to Buy from Neutral at BofA
05/02/22 Morgan Stanley
Nio's April sales 'crimped' by lockdowns, says Morgan Stanley
BARK Bark
$2.17 /

-0.29 (-11.79%)

06/01/22 Canaccord
Original Bark Company price target lowered to $8 from $10 at Canaccord
02/11/22 Canaccord
Original Bark Company price target lowered to $12 from $16 at Canaccord
11/18/21 Citi
Original Bark Company price target lowered to $14 from $16 at Citi
06/28/21 Citi
Original Bark Company initiated with a Buy at Citi
LX LexinFintech
$1.88 /

-0.135 (-6.70%)

06/01/22 CLSA
LexinFintech downgraded to Sell from Outperform at CLSA
05/31/22 Citi
LexinFintech downgraded to Neutral from Buy at Citi
12/20/21 UBS
LexinFintech downgraded to Neutral from Buy at UBS
08/26/21 DBS Bank
LexinFintech downgraded to Hold from Buy at DBS Bank
VSCO Victoria's Secret
$43.57 /

+2.295 (+5.56%)

VRTX Vertex Pharmaceuticals
$267.07 /

-1.42 (-0.53%)

TWTR Twitter
$39.51 /

-0.23 (-0.58%)

TSLA Tesla
$737.88 /

-20.13 (-2.66%)

TPX Tempur Sealy
$24.99 /

-1.385 (-5.25%)

SQ Block
$82.73 /

-4.76 (-5.44%)

SPGI S&P Global
$337.39 /

-12.56 (-3.59%)

NIO Nio
$17.96 /

+0.55 (+3.16%)

MDT Medtronic
$96.53 /

-3.64 (-3.63%)

HUM Humana
$446.94 /

-6.58 (-1.45%)

HPQ HP Inc.
$39.75 /

+0.99 (+2.55%)

GDRX GoodRx
$7.36 /

-0.6 (-7.54%)

FB Ticker changed to META
$193.20 /

-0.355 (-0.18%)

DAL Delta Air Lines
$39.67 /

-2.02 (-4.85%)

CRM Salesforce
$176.91 /

+16.31 (+10.16%)

CPRI Capri Holdings
$49.03 /

+0.27 (+0.55%)

CMAX CareMax
$5.30 /

+0.62 (+13.25%)

BPMC Blueprint Medicines
$55.22 /

+0.34 (+0.62%)

BITF Bitfarms
$1.89 /

-0.135 (-6.67%)

BARK Bark
$2.17 /

-0.29 (-11.79%)

APPS Digital Turbine
$19.97 /

-5.5 (-21.59%)

AMBA Ambarella
$82.77 /

-2.46 (-2.89%)

AFRM Affirm
$24.33 /

-4.13 (-14.51%)

AAPL Apple
$148.33 /

-0.48 (-0.32%)

VRTX Vertex Pharmaceuticals
$267.07 /

-1.42 (-0.53%)

TWTR Twitter
$39.51 /

-0.23 (-0.58%)

TSLA Tesla
$737.88 /

-20.13 (-2.66%)

SQ Block
$82.73 /

-4.76 (-5.44%)

OPA Magnum Opus Acquisition
$9.79 /

-0.045 (-0.46%)

NIO Nio
$17.96 /

+0.55 (+3.16%)

META Meta Platforms
/

+

MDT Medtronic
$96.53 /

-3.64 (-3.63%)

HUM Humana
$446.94 /

-6.58 (-1.45%)

HPQ HP Inc.
$39.75 /

+0.99 (+2.55%)

FB Ticker changed to META
$193.20 /

-0.355 (-0.18%)

ENOB Enochian Biosciences
$3.66 /

-1.595 (-30.38%)

DAL Delta Air Lines
$39.67 /

-2.02 (-4.85%)

CRM Salesforce
$176.91 /

+16.31 (+10.16%)

AFRM Affirm
$24.33 /

-4.13 (-14.51%)

AAPL Apple
$148.33 /

-0.48 (-0.32%)

VSCO Victoria's Secret
$43.57 /

+2.295 (+5.56%)

VRTX Vertex Pharmaceuticals
$267.07 /

-1.42 (-0.53%)

TSLA Tesla
$737.88 /

-20.13 (-2.66%)

TPX Tempur Sealy
$24.99 /

-1.385 (-5.25%)

SQ Block
$82.73 /

-4.76 (-5.44%)

SPGI S&P Global
$337.39 /

-12.56 (-3.59%)

OPA Magnum Opus Acquisition
$9.79 /

-0.045 (-0.46%)

NIO Nio
$17.96 /

+0.55 (+3.16%)

META Meta Platforms
/

+

MDT Medtronic
$96.53 /

-3.64 (-3.63%)

HUM Humana
$446.94 /

-6.58 (-1.45%)

HPQ HP Inc.
$39.75 /

+0.99 (+2.55%)

GDRX GoodRx
$7.36 /

-0.6 (-7.54%)

FB Ticker changed to META
$193.20 /

-0.355 (-0.18%)

DAL Delta Air Lines
$39.67 /

-2.02 (-4.85%)

CRM Salesforce
$176.91 /

+16.31 (+10.16%)

CPRI Capri Holdings
$49.03 /

+0.27 (+0.55%)

BITF Bitfarms
$1.89 /

-0.135 (-6.67%)

BARK Bark
$2.17 /

-0.29 (-11.79%)

APPS Digital Turbine
$19.97 /

-5.5 (-21.59%)

AMBA Ambarella
$82.77 /

-2.46 (-2.89%)

AFRM Affirm
$24.33 /

-4.13 (-14.51%)

AAPL Apple
$148.33 /

-0.48 (-0.32%)

VSCO Victoria's Secret
$43.57 /

+2.295 (+5.56%)

VRTX Vertex Pharmaceuticals
$267.07 /

-1.42 (-0.53%)

TWTR Twitter
$39.51 /

-0.23 (-0.58%)

TSLA Tesla
$737.88 /

-20.13 (-2.66%)

TPX Tempur Sealy
$24.99 /

-1.385 (-5.25%)

SQ Block
$82.73 /

-4.76 (-5.44%)

SPGI S&P Global
$337.39 /

-12.56 (-3.59%)

RBAC RedBall Acquisition
$9.95 /

+0.57 (+6.08%)

NIO Nio
$17.96 /

+0.55 (+3.16%)

META Meta Platforms
/

+

MDT Medtronic
$96.53 /

-3.64 (-3.63%)

LX LexinFintech
$1.88 /

-0.135 (-6.70%)

HUM Humana
$446.94 /

-6.58 (-1.45%)

HPQ HP Inc.
$39.75 /

+0.99 (+2.55%)

GDRX GoodRx
$7.36 /

-0.6 (-7.54%)

FB Ticker changed to META
$193.20 /

-0.355 (-0.18%)

DAL Delta Air Lines
$39.67 /

-2.02 (-4.85%)

CRM Salesforce
$176.91 /

+16.31 (+10.16%)

CPRI Capri Holdings
$49.03 /

+0.27 (+0.55%)

BITF Bitfarms
$1.89 /

-0.135 (-6.67%)

BARK Bark
$2.17 /

-0.29 (-11.79%)

APPS Digital Turbine
$19.97 /

-5.5 (-21.59%)

AMBA Ambarella
$82.77 /

-2.46 (-2.89%)

AFRM Affirm
$24.33 /

-4.13 (-14.51%)

AAPL Apple
$148.33 /

-0.48 (-0.32%)

Downgrade
LexinFintech downgraded to Sell from Outperform at CLSA » 05:15
06/01/22
06/01
05:15
06/01/22
05:15
LX

LexinFintech

$2.02 /

-0.36 (-15.16%)

CLSA analyst Ethan Wang…

CLSA analyst Ethan Wang downgraded LexinFintech to Sell from Outperform with a price target of $2.10, down from $3.21. Due to the regulatory cap on loan rate and pressure from guarantee and funding partners, the company "needs more years to recover," Wang tells investors in a research note. The analyst is worried about LexinFintech's take rate declining at a much faster rate than its peers.

ShowHide Related Items >><<
LX LexinFintech
$2.02 /

-0.36 (-15.16%)

LX LexinFintech
$2.02 /

-0.36 (-15.16%)

05/31/22 Citi
LexinFintech downgraded to Neutral from Buy at Citi
12/20/21 UBS
LexinFintech downgraded to Neutral from Buy at UBS
08/26/21 DBS Bank
LexinFintech downgraded to Hold from Buy at DBS Bank
08/26/21 Citi
LexinFintech price target lowered to $9.89 from $18.55 at Citi
LX LexinFintech
$2.02 /

-0.36 (-15.16%)

Downgrade
LexinFintech downgraded to Neutral from Buy at Citi » 10:57
05/31/22
05/31
10:57
05/31/22
10:57
LX

LexinFintech

$1.99 /

-0.39 (-16.42%)

Citi analyst Julia Cheung…

Citi analyst Julia Cheung downgraded LexinFintech to Neutral from Buy with a price target of $2.44, down from $4.29, citing a "dimmer near-term earnings outlook" after the company reported Q1 results and full-year guidance. Despite "soft" loan volume growth in Q1, LexinFintech maintained its loan origination volume growth for 2022 at 10% year-over-year, noted Cheung.

ShowHide Related Items >><<
LX LexinFintech
$1.99 /

-0.39 (-16.42%)

LX LexinFintech
$1.99 /

-0.39 (-16.42%)

12/20/21 UBS
LexinFintech downgraded to Neutral from Buy at UBS
08/26/21 DBS Bank
LexinFintech downgraded to Hold from Buy at DBS Bank
08/26/21 Citi
LexinFintech price target lowered to $9.89 from $18.55 at Citi
LX LexinFintech
$1.99 /

-0.39 (-16.42%)

Hot Stocks
Autohome appoints Craig Yan Zeng as CFO » 06:15
05/06/22
05/06
06:15
05/06/22
06:15
ATHM

Autohome

$28.00 /

-2.145 (-7.12%)

, LX

LexinFintech

$2.69 /

-0.075 (-2.72%)

Autohome (ATHM) announced…

Autohome (ATHM) announced the appointment of Craig Yan Zeng as its CFO, effective immediately. Craig Yan Zeng has over 20 years of experience in capital market and has held senior management positions in many companies. He has been a director of LexinFintech (LX) since December 2017 and served as the chief financial officer of LexinFintech from November 2016 to June 2021.

ShowHide Related Items >><<
LX LexinFintech
$2.69 /

-0.075 (-2.72%)

ATHM Autohome
$28.00 /

-2.145 (-7.12%)

ATHM Autohome
$28.00 /

-2.145 (-7.12%)

04/28/22 Citi
Autohome upgraded to Buy from Neutral at Citi
03/14/22 JPMorgan
Autohome price target lowered to $25 from $33 at JPMorgan
02/28/22 Benchmark
Autohome upgraded to Buy from Hold at Benchmark
02/25/22 Citi
Autohome price target lowered to $30 from $36 at Citi
LX LexinFintech
$2.69 /

-0.075 (-2.72%)

12/20/21 UBS
LexinFintech downgraded to Neutral from Buy at UBS
08/26/21 DBS Bank
LexinFintech downgraded to Hold from Buy at DBS Bank
08/26/21 Citi
LexinFintech price target lowered to $9.89 from $18.55 at Citi
08/02/21
LexinFintech downgraded to Outperform from Buy at CLSA
ATHM Autohome
$28.00 /

-2.145 (-7.12%)

ATHM Autohome
$28.00 /

-2.145 (-7.12%)

LX LexinFintech
$2.69 /

-0.075 (-2.72%)

Hot Stocks
LexinFintech updates status under HFCAA » 07:28
05/05/22
05/05
07:28
05/05/22
07:28
LX

LexinFintech

$2.76 /

+0.07 (+2.60%)

LexinFintech Holdings…

LexinFintech Holdings updates its status under the Holding Foreign Companies Accountable Act. The Company was provisionally named by the United States Securities and Exchange Commission as a Commission-Identified Issuer on May 4, 2022, following the Company's filing of the annual report on Form 20-F for the fiscal year ended December 31, 2021 with the SEC on April 29, 2022. The Company understands that this identification under the HFCAA and its implementation rules issued thereunder indicates that the SEC determines that the Company used a registered public accounting firm whose working paper cannot be inspected or investigated completely by the Public Company Accounting Oversight Board of the United States to issue the audit opinion for its financial statements for the fiscal year ended December 31, 2021. In accordance with the HFCAA, the SEC shall prohibit a company's shares or American depositary shares from being traded on a national stock exchange or in the over-the-counter trading market in the United States if the company has been identified by the SEC for three consecutive years due to PCAOB's inability to inspect the auditor's working paper. The Company has been actively exploring possible solutions to protect the interest of its stakeholders. The Company will continue to comply with applicable laws and regulations in both China and the United States and strive to maintain its listing status on the Nasdaq Stock Market.

ShowHide Related Items >><<
LX LexinFintech
$2.76 /

+0.07 (+2.60%)

LX LexinFintech
$2.76 /

+0.07 (+2.60%)

12/20/21 UBS
LexinFintech downgraded to Neutral from Buy at UBS
08/26/21 DBS Bank
LexinFintech downgraded to Hold from Buy at DBS Bank
08/26/21 Citi
LexinFintech price target lowered to $9.89 from $18.55 at Citi
08/02/21
LexinFintech downgraded to Outperform from Buy at CLSA
LX LexinFintech
$2.76 /

+0.07 (+2.60%)

Over a quarter ago
Hot Stocks
LexinFintech announces $50M share repurchase program » 05:13
03/16/22
03/16
05:13
03/16/22
05:13
LX

LexinFintech

$2.16 /

+0.075 (+3.61%)

LexinFintech announced…

LexinFintech announced that its board of directors has authorized a share repurchase program under which the company may purchase up to $50M of its shares over the next twelve months.

ShowHide Related Items >><<
LX LexinFintech
$2.16 /

+0.075 (+3.61%)

LX LexinFintech
$2.16 /

+0.075 (+3.61%)

12/20/21 UBS
LexinFintech downgraded to Neutral from Buy at UBS
08/26/21 DBS Bank
LexinFintech downgraded to Hold from Buy at DBS Bank
08/26/21 Citi
LexinFintech price target lowered to $9.89 from $18.55 at Citi
08/02/21
LexinFintech downgraded to Outperform from Buy at CLSA
LX LexinFintech
$2.16 /

+0.075 (+3.61%)

Options
LexinFintech options imply 15.0% move in share price post-earnings » 15:11
03/15/22
03/15
15:11
03/15/22
15:11
LX

LexinFintech

$2.15 /

+0.07 (+3.37%)

Pre-earnings options…

Pre-earnings options volume in LexinFintech is 4.6x normal with calls leading puts :. Implied volatility suggests the market is anticipating a move near 15.0%, or 32c, after results are released. Median move over the past eight quarters is 12.9%.

ShowHide Related Items >><<
LX LexinFintech
$2.15 /

+0.07 (+3.37%)

LX LexinFintech
$2.15 /

+0.07 (+3.37%)

12/20/21 UBS
LexinFintech downgraded to Neutral from Buy at UBS
08/26/21 DBS Bank
LexinFintech downgraded to Hold from Buy at DBS Bank
08/26/21 Citi
LexinFintech price target lowered to $9.89 from $18.55 at Citi
08/02/21
LexinFintech downgraded to Outperform from Buy at CLSA
Downgrade
LexinFintech downgraded to Neutral from Buy at UBS » 10:14
12/20/21
12/20
10:14
12/20/21
10:14
LX

LexinFintech

$3.53 /

-0.165 (-4.47%)

UBS downgraded…

UBS downgraded LexinFintech to Neutral from Buy with a $4.30 price target.

ShowHide Related Items >><<
LX LexinFintech
$3.53 /

-0.165 (-4.47%)

LX LexinFintech
$3.53 /

-0.165 (-4.47%)

08/26/21 DBS Bank
LexinFintech downgraded to Hold from Buy at DBS Bank
08/26/21 Citi
LexinFintech price target lowered to $9.89 from $18.55 at Citi
08/02/21
LexinFintech downgraded to Outperform from Buy at CLSA
06/14/21 Morgan Stanley
LexinFintech upgraded to Overweight from Equal Weight at Morgan Stanley
Hot Stocks
LexinFintech senior management to purchase up to $10M of ADSs » 05:26
12/01/21
12/01
05:26
12/01/21
05:26
LX

LexinFintech

$4.19 /

-0.12 (-2.79%)

LexinFintech announced…

LexinFintech announced that members of its senior management have informed the company that they planned to use their personal funds to purchase the company's American depository shares, or ADSs, and some purchases had been made in the past few days. Led by chairman and CEO Jay Wenjie Xiao, president Jared Yi Wu, CFO Sunny Rui Sun, chief financing cooperation officer Kris Qian Qiao, chief human resource officer Shirley Yunwen Yang and chief marketing officer Jason Ming Zhao, the members intend to continue the purchase to up to $10M worth of the ADSs within the next six months, pursuant and subject to applicable laws and the company's securities trading policy.

ShowHide Related Items >><<
LX LexinFintech
$4.19 /

-0.12 (-2.79%)

LX LexinFintech
$4.19 /

-0.12 (-2.79%)

08/26/21 DBS Bank
LexinFintech downgraded to Hold from Buy at DBS Bank
08/26/21 Citi
LexinFintech price target lowered to $9.89 from $18.55 at Citi
08/02/21
LexinFintech downgraded to Outperform from Buy at CLSA
06/14/21 Morgan Stanley
LexinFintech upgraded to Overweight from Equal Weight at Morgan Stanley
Downgrade
LexinFintech downgraded to Hold from Buy at DBS Bank » 06:55
08/26/21
08/26
06:55
08/26/21
06:55
LX

LexinFintech

$6.97 /

-1.09 (-13.52%)

DBS Bank analyst Cindy…

DBS Bank analyst Cindy Wang downgraded LexinFintech to Hold from Buy with a $7.20 price target.

ShowHide Related Items >><<
LX LexinFintech
$6.97 /

-1.09 (-13.52%)

LX LexinFintech
$6.97 /

-1.09 (-13.52%)

08/26/21 Citi
LexinFintech price target lowered to $9.89 from $18.55 at Citi
08/02/21
LexinFintech downgraded to Outperform from Buy at CLSA
06/14/21 Morgan Stanley
LexinFintech upgraded to Overweight from Equal Weight at Morgan Stanley
06/14/21 Morgan Stanley
LexinFintech upgraded to Overweight from Equal Weight at Morgan Stanley

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.